Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing | Ono ...

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that ...

After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic ...

Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...

A day after the Physics prize was given to two scientists for foundational work on machine learning, the Nobel Prize in ...

Syneos Health has tapped Costa Panagos to take the reins from former CEO Colin Shannon, who will transition to the role of ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of ...